OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results

Aug 3, 2023

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jul 25, 2023

FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

Jun 28, 2023

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

May 3, 2023

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

Apr 25, 2023

OPKO Health to Hold Virtual R&D Day on March 20, 2023

Mar 9, 2023

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

Mar 8, 2023

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

Feb 23, 2023

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

Feb 16, 2023

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

Jan 3, 2023